| Dataset:27714496 Search Result | |||||||
| Clinical Information | |||||||
| Demographic characteristics and viral investigation of five patients infected with H275Y mutant viruses in 2016 | |||||||
| Cases | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | ||
| Patient information | Age (years) | 75 | 41 | 37 | 1 | 2 | |
| Sex | Female | Male | Female | Female | Female | ||
| Area in Japan | Niigata | Nagasaki | Nagasaki | Niigata | Niigata | ||
| Date of fever onset | 25-Jan | 9-Jan | 10-Jan | 5-Feb | 12-Feb | ||
| Date of therapy start | 25-Jan | 11-Jan | 11-Jan | 6-Feb | 12-Feb | ||
| NAIs used | Peramivir | Oseltamivir | Peramivir | Oseltamivir | Oseltamivir | ||
| Fever duration(days) | 1 | 1 | 3 | 3 | 2 | ||
| Travel history | No | No | Yesa | No | No | ||
| History of NAI treatment | Yesb | No | No | No | No | ||
| Oseltamivir | |||||||
| Underlying condition | Yesc | No | No | No | No | ||
| Hospitalization | Yesc | No | No | No | No | ||
| Viral investigations | Date of sample collection | 25-Jan | 11-Jan | 11-Jan | 6-Feb | 12-Feb | |
| Strain name | A/Niigata/15NU001/2016 | A/Nagasaki/15N002/2016 | A/Nagasaki/15N005/2016 | A/Niigata/15F255/2016 | A/Niigata/15F341/2016 | ||
| Neuraminidase inhibition assay | Oseltamivir | 353.38 ± 13.32 | 321.59 ± 19.81 | 352.59 ± 23.03 | 320.38 ± 50.33 | 346.31 ± 44.37 | |
| (IC50) [nM]d | Peramivir | 19.67 ± 2.82 | 23.88 ± 1.72 | 22.30 ± 0.83 | 20.10 ± 1.68 | 18.77 ± 0.70 | |
| Zanamivir | 0.74 ± 0.03 | 0.74 ± 0.04 | 0.69 ± 0.07 | 0.79 ± 0.042 | 0.69 ± 0.08 | ||
| Laninamivir | 0.83 ± 0.03 | 0.74 ± 0.02 | 0.75 ± 0.01 | 0.94 ± 0.13 | 0.84 ± 0.07 | ||
| NA enzyme kinetics parametere | Km [μM] | 33.42 ± 5.15 | 73.22 ± 27.65 | 61.79 ± 12.10 | 29.48 ± 4.78 | 27.04 ± 3.02 | |
| Vmax[μM/min] | 0.33 ± 0.02 | 0.56 ± 0.31 | 0.40 ± 0.03 | 0.45 ± 0.06 | 0.31 ± 0.02 | ||